Work

ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) + Utomilumab Patients with Refractory Large B Cell Lymphoma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-123772

Authors: Ran Reshef, David B. Miklos, John M. Timmerman, Caron A. Jacobson, Nabila N. Bennani, John M. Rossi, Marika Sherman, Lianqing Zheng, Jennifer Sun, Gabrielle Palluconi, Jenny J. Kim, Michael D. Jain

Institutions: Columbia University Irving Medical Center, Stanford Medicine, Stanford University, University of California, Los Angeles, Dana-Farber Cancer Institute, Mayo Clinic, Kite (United States), Kite Pharma (United States), Moffitt Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983526252

Cites:

Cited by: 6

Related to: 10